Floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning Subscale among patients with advanced or

Meena N Murugappan1, Bellinda L King-Kallimanis2, Christina Mangir3

  • 1Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.

Cancer
|October 11, 2021
PubMed
Abstract